Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 10-2010 | 09-2010 | 07-2010 | 06-2010 | 04-2010 | |
| Sales | 120 | 120 | 0 | 1,066 | 531 |
| Cost of Goods | 495 | 523 | N/A | 931 | 697 |
| Gross Profit | -375 | -403 | N/A | 135 | -166 |
| Operating Expenses | 1,212 | 1,212 | 0 | 1,533 | 1,269 |
| Operating Income | -1,093 | -1,093 | N/A | -467 | -738 |
| Interest Expense | 2 | 2 | 0 | 2 | 2 |
| Pre-tax Income | -1,094 | -1,094 | 0 | -468 | -740 |
| Net Income Continuous | -1,094 | -1,094 | N/A | -468 | -740 |
| Net Income | $-1,094 | $-1,094 | $N/A | $-468 | $-740 |
| EPS Basic Total Ops | -0.08 | -0.08 | N/A | -0.04 | -0.07 |
| EPS Basic Continuous Ops | -0.08 | -0.08 | N/A | -0.04 | -0.07 |
| EPS Diluted Total Ops | -0.08 | -0.08 | N/A | -0.04 | -0.07 |
| EPS Diluted Continuous Ops | -0.08 | -0.08 | N/A | -0.04 | -0.07 |
| EBITDA(a) | $-1,078 | $-1,078 | $N/A | $-455 | $-726 |